Clinical trial
Prospective Randomized Controlled Trial Comparing Infection Rates and Wound Closure Following Transmetatarsal Amputation With Aid of Electrospun Fiber Matrix
NCT06063694 is registered in ClinicalTrials.gov with Scripps Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Randomized Controlled Trial Comparing Infection Rates and Wound Closure Following Transmetatarsal Amputation With Aid of Electrospun Fiber Matrix
- Lead sponsor
- Scripps Health
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2024
- Completion date
- November 30, 2024
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
amputation, wound complication, wound; foot